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OBJECTIVE — Patients with diabetes suffer high rates of mental health problems, and this
combination is associated with poor outcomes. Although effective treatments exist for both
diabetes and mental health problems, delivering services for physical and mental health prob-
lemsseparatelyignorestheirinteractionandmaybeinefﬁcient.Thissystematicreviewsoughtto
identify psychosocial interventions that could improve both the physical and mental health of
patients with diabetes.
RESEARCH DESIGN AND METHODS — Studies were identiﬁed from the following
databases: CENTRAL, MEDLINE, Excerpta Medica (EMBASE), Psychinfo, and Cumulative In-
dex to Nursing and Allied Health Literature (CINAHL). The review included randomized con-
trolled trials in patients with type 1 and type 2 diabetes who received psychosocial interventions
and where both mental health and physical health outcomes were reported. Data were extracted
on study quality, the content and process of interventions, and outcomes.
RESULTS — Eighty-ﬁveeligiblecomparisonswereidentiﬁed,ofwhich49reportedsufﬁcient
data for analysis. Psychosocial interventions modestly improved A1C (standardized mean dif-
ference 0.29 [95% CI 0.37 to 0.21]) and mental health outcomes (0.16 [0.25 to
0.07]).However,therewasalimitedassociationbetweentheeffectsonA1Candmentalhealth,
and no intervention characteristics predicted beneﬁt on both outcomes.
CONCLUSIONS — Managing physical and mental health in long-term conditions are in-
creasinglyimportant.Thereviewdidnotidentifytypesofinterventionsthatconsistentlyprovide
beneﬁts for both physical and mental health. Developing such interventions remains an impor-
tant challenge. The ﬁndings have implications for understanding the interaction between phys-
ical and mental health problems and for the coordination of care.
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D
iabetes is a major cause of mortality
and morbidity (1). Comorbidity
(thepresenceofotherconditions)is
highlyprevalent(2),andpatientswithdi-
abetes have elevated rates of mental
health problems such as depression (3).
Diabetesandmentalhealthinteractin
harmful ways (4). Patients with diabetes
and mental health problems are less ad-
herenttomedicalcare(5)andsuffermore
complications (6). Comorbid depression
and diabetes result in worse health out-
comes than other combinations of
chronic disease (7).
Although effective treatments exist
for both diabetes and mental health prob-
lems, these are often delivered separately.
This is potentially inefﬁcient and incon-
venientforpatients,andcanleadtoprob-
lems in care coordination (8). Ignoring
comorbidityalsocausesmissedtherapeu-
tic opportunities. Reducing depressive
symptoms might improve patient self-
managementwithconsequentbeneﬁtsfor
diabetes outcomes. Improved diabetes
control might reduce distress associated
with complications and poor physical
health.
Identifying interventions that impact
both mental health and diabetes out-
comes simultaneously would allow prac-
titioners to provide truly biopsychosocial
care, to improve efﬁciency, and could re-
duce problems in coordinating care.
Although there is evidence that psycho-
logical interventions improve mental
health in some studies and diabetic con-
trol in others (9,10), achieving simulta-
neous improvements in both outcomes is
a far greater challenge (11). Effective
treatment of depressive symptoms in pa-
tients with diabetes often fails to improve
glycemic control (12) and vice versa (13).
Thissystematicreviewaimedtoiden-
tify psychosocial interventions that im-
proved both the physical and mental
health of patients with diabetes.
RESEARCH DESIGN AND
METHODS— The review is reported
according to the Preferred Reporting
Items for Systematic reviews and Meta-
Analyses (PRISMA) guidelines (14).
There was no formal published protocol.
Eligible studies were randomized
controlled trials including patients of all
ages with both type 1 and type 2 diabetes
receiving a psychosocial intervention,
which was deﬁned as either 1) lifestyle
intervention to manage diabetes (e.g., ed-
ucation,skillstraining,andexerciseinter-
ventions)or2)psychologicalintervention
to manage mental health (e.g., problem
solving, cognitive-behavior therapy, and
social support).
These interventions were compared
with studies using no treatment, waiting
list, or usual care comparators. Studies
wereexcludediftheindependenteffectof
a psychosocial intervention could not be
determined (e.g., a combined antidepres-
sant medication and counseling interven-
tion compared with usual care).
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mental and physical health outcomes. To
maximizecomparability,glycosylatedhe-
moglobin (A1C) was used as the sole
physical health outcome. Standardized
measures of depression, anxiety, or men-
tal health were used as mental health out-
comes. Diabetes-speciﬁc outcomes (e.g.,
diabetes-related quality of life or adjust-
ment to diabetes) were excluded to avoid
confounding with physical health
outcomes.
Information sources and search
strategy
The comprehensive coverage of the
CENTRAL database makes exhaustive
searching of individual bibliographic da-
tabases unnecessary (15). We therefore
carried out a search of the CENTRAL da-
tabase of controlled trials on the Co-
chraneLibrary(Issue2,2007).Toidentify
recently published trials, additional
searches were conducted in MEDLINE and
EMBASE.Wealsocarriedoutafullsearch
of Psychinfo (1985–2007) and CINAHL
(1980–2007) using the ﬁrst two stages
only of the Cochrane Highly Sensitive
Search Strategy for randomized con-
trolled trials to identify any further trials
not identiﬁed by the other searches. All
searches were carried out between April
and August 2007 and updated in April
2009. Electronic searches were aug-
mented by checking 24 reviews of diabe-
tes care. The full search strategy is
provided in the online appendix (avail-
able at http://care.diabetesjournals.org/
cgi/content/full/dc09-1519/DC1). Non-
English publications were translated.
Potentiallyeligiblestudieswereidentiﬁed
by title and abstract and the full text was
obtained to check eligibility.
Analytic methods
The different components in each inter-
vention were categorized, and data were
extracted on intervention intensity (num-
ber of sessions, duration), setting (e.g.,
primary care, hospital), the professionals
involved, delivery method (e.g., individ-
ualorgroup,face-to-faceorremotedeliv-
ery), and quality control (training,
supervision, written manuals, and assess-
ments of adherence or competence). Pa-
tient characteristics included age, type of
diabetes, and whether patients were re-
cruitedonthebasisofeitherpoordiabetic
control or identiﬁed depression.
Methodological quality at the level of
the study was assessed by two indepen-
dent reviewers who rated sequence gen-
eration,allocationconcealment,blinding,
intention-to-treat analyses, and attrition.
For analysis, a binary measure of alloca-
tion concealment served as the primary
quality measure (16).
Continuous outcome measures were
translated to a standardized effect size
(mean of intervention group minus mean
of control group, divided by the pooled
standard deviation). Negative effect sizes
corresponded to positive outcomes for
the intervention compared with the con-
trol (i.e., reductions in A1C or depressive
symptoms). Dichotomous outcomes,
missing SDs, and other nonstandard data
formats were dealt with using conven-
tional methods (17,18). The outcome
data closest to 6-months follow-up was
used to maximize consistency across the
studies. Where the studies reported two
interventions versus a control group,
sample sizes were halved to avoid double
counting. All coding was done by groups
oftworatersworkingindependentlywith
disagreements resolved by discussion.
Initial meta-analyses using random
effects modeling were conducted to esti-
mate the pooled effect of psychosocial in-
terventions, to allow calculation of the I
2
statistic to quantify heterogeneity (19),
and to explore publication bias. Publica-
tion bias is where published research is
systematically unrepresentative of the
population of completed studies (20). A
funnel plot (21) plots effect size against
theSEoftheeffectsize.Asymmetryinthe
plot is often related to an absence of small
studies with small effect sizes, which is
suggestive of publication bias. Asymme-
try can be formally tested through the
Egger regression method (21).
The main aim was to identify the
characteristics of psychosocial interven-
tions that impacted on both mental and
physical health outcomes. The associa-
tionbetweentheeffectofpsychosocialin-
terventionsonphysicalandmentalhealth
outcomes was examined using scatter-
plots and the Pearson correlation coefﬁ-
cient. The primary analysis examined the
association between intervention charac-
teristics and outcomes using random ef-
fects meta-regression (22). Associations
may be confounded by study characteris-
tics other than the intervention, particu-
larly methodological quality and patient
characteristics. Initial analyses examined
the univariate relationship between allo-
cation concealment and patient charac-
teristics, and each outcome in turn. If
allocation concealment or patient charac-
teristics were signiﬁcant (using the liberal
criteria of P  0.10) in these univariate
analyses, they were then entered into the
meta-regression models, together with
each intervention characteristic. This ap-
proach examined whether intervention
characteristics were signiﬁcant predictors
of variation in outcomes over and above
differences in study quality and patient
populations.
Separate meta-regressions were con-
ducted on physical and mental health
outcomes, to identify intervention char-
acteristics that predicted each individual
outcome, and those that were signiﬁcant
predictors across both outcomes. The re-
gression coefﬁcient represents the differ-
ence in effect size between studies with
different characteristics, either different
levels of categorical variables (e.g., pres-
enceofexerciseintheintervention)orthe
change in effect size associated with a
one-unitincreaseinacontinuousvariable
(e.g., each hour of additional treatment).
Analyses were conducted in Stata version
9, using the metan and metareg macros.
RESULTS— We identiﬁed 652 poten-
tially relevant abstracts, and included 73
studies reporting 85 relevant compari-
sons (supplemental Fig. 1). Of these, 49
comparisons included data for meta-
analysis. Supplemental Table 1 provides
descriptive data on the studies, interven-
tions, and study quality.
The characteristics of and references
toindividualstudiesareshowninsupple-
mental Tables 2 and 3. The majority of
studies were in specialist settings, using
patients aged over 50 years with type 2
diabetes.Onlyaminorityofpatientswere
speciﬁcally recruited on the basis of poor
diabeticcontrol(22%)orbaselinedepres-
sion (10%). Interventions were delivered
by a range of professionals and peers, and
the bulk were delivered face to face with
anequalsplitbetweengroupandindivid-
ual interventions. Fifty-three percent of
interventions focused on lifestyle alone,
29% focused on mental health, and 18%
targetedboth.Themostcommonlifestyle
interventions were education and theory-
based psychological treatments such as
cognitive-behavior therapy. Psychologi-
cal interventions were more varied, in-
cluding cognitive-behavior therapy,
social support, and relaxation. Approxi-
mately half the studies used a speciﬁc de-
pression outcome, and the rest used a
combination of mental health scales (e.g.,
the SF36 mental component scale) or
anxiety scales. The mean length of fol-
low-up was 6.8 months (SD 5.9).
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interventions on physical and
mental health outcomes
Psychosocial interventions were associ-
ated with modest improvements in A1C
(standardized mean difference 0.29
[95% CI 0.37 to 0.21], I
2  45%)
(supplemental Fig. 2) and smaller im-
provements in mental health (0.16,
0.25 to 0.07, I
2  56%) (supplemen-
tal Fig. 3). These results were consistent
across studies using different mental
health outcomes (e.g., depression vs.
mental health quality of life or anxiety).
Interventions focused on lifestyle alone
were not signiﬁcantly more effective in
controlling A1C than those focused on
mental health or combined interventions.
Interventions including both a lifestyle
and a mental health component were sig-
niﬁcantly more effective than lifestyle in-
terventions alone in improving mental
health.
There was evidence of funnel plot
asymmetry in both meta-analyses (sup-
plemental Fig. 4 and 5).
Association between effects of
interventions on physical and
mental health outcomes
The scatterplot of mental health and
physical health outcomes is shown in Fig.
1. The relationship between the effect of
interventions on mental health and A1C
was modest and not statistically signiﬁ-
cant (Pearson r  0.25, P  0.08). One
study was an outlier on both outcomes
and post hoc removal of that study re-
duced the correlation markedly (Pearson
r  0.11, P  0.45). Using conventional
criteria for the magnitude of effect sizes,
only ﬁve (10%) studies reported at least
“medium”effectsonbothoutcomes(stan-
dardized mean difference of 0.5 or
greater) and only 11 (23%) reported at
least“small”effectsonboth(standardized
mean difference of 0.2 or greater).
Meta-regression to identify study
characteristics associated with
physical and mental health
outcomes
Allocation concealment did not predict
A1C. The beneﬁts of psychosocial inter-
ventions on A1C were less in elderly
(mean age 50 years) patients (coefﬁ-
cient 0.16 [95% CI 0.02 to 0.34]) and
greater in those recruited on the basis of
poor baseline diabetes control (0.17
[0.37 to 0.03]).
In the multivariate model including
age and poor baseline diabetes control,
the beneﬁts of psychosocial interventions
onA1Cweregreateronlyininterventions
that included education and skills train-
ing (0.17 [0.33 to 0.01]).
Allocation concealment did not pre-
dictbeneﬁtsofpsychosocialinterventions
on mental health, but beneﬁts were
greater in those studies recruited speciﬁ-
cally on the basis of poor mental health
(0.36 [0.67 to 0.06]).
In the multivariate model including
recruitment on the basis of mental health,
the beneﬁts of psychosocial interventions
onmentalhealthweregreaterininterven-
tions including other psychological ther-
apies (0.29 [0.57 to 0.01]).
CONCLUSIONS — The study aimed
toidentifypsychosocialinterventionsthat
improved both physical and mental
health in patients with diabetes. This
could arise through the effective integra-
tion of physical and mental health inter-
ventions into a single package or through
positive interactions (e.g., where im-
provements in lifestyle and physical out-
comes impacted on mental health or vice
versa).
However, the analysis suggested that
very few such interventions have been
identiﬁed, and that there are no charac-
teristics of interventions that predict sub-
stantial beneﬁts in both outcomes.
Despite the potential interactions be-
tween mental health and diabetes, a com-
mon therapeutic pathway has proven
elusive.
Limitations of the study
There was signiﬁcant variation in inter-
ventions,patientpopulations,studyqual-
ity, and follow-up times, raising concerns
about pooling outcomes with clinical and
methodological heterogeneity. We maxi-
mized homogeneity through the use of
A1C as a common outcome and by stan-
dardizing the follow-up period as much
as possible. We also note that estimates of
statisticalheterogeneityweremoderateby
current convention (19). More impor-
tantly, the analytic focus was on the rela-
tionships between outcomes (Fig. 1) and
the meta-regression. Meta-regression
does not assume homogeneity but specif-
ically seeks to explore variation in
outcomes.
Patientsrecruitedonthebasisofpoor
diabetic control showed greater impact
from psychosocial interventions. This
may reﬂect their greater capacity to bene-
ﬁt, as poor control may reﬂect deﬁcits in
knowledgeandskillsthatareamenableto
change. Similarly, only 10% of studies
speciﬁcally recruited patients based on
mental health problems at baseline, and
again, this was a signiﬁcant predictor of
beneﬁt.Theresultsmayrepresenta“ﬂoor
effect” among patients who were not sig-
niﬁcantlydistressedandthereforehadlit-
tle room for improvement in symptoms.
However, even though most patients
werenotrecruitedonthebasisofamental
health problem, they were not excluded
on that basis either. Epidemiological
work has shown that any unselected sam-
ple of patients with diabetes will include
Figure 1—Scatterplot of the standardized effect on A1C and mental health outcomes.
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(3)andotherswithsigniﬁcantsymptoms,
whereaninterventionmayhaveapreven-
tive effect. There is evidence that the ef-
fects of depression on diabetes self-care
are present across the whole range of
symptoms, and that even mild levels of
depression are associated with important
levels of nonadherence (23).
Unlike previous analyses (9), the cur-
rent study excluded psychological out-
comes such as diabetes-speciﬁc quality of
life and self-efﬁcacy. These are likely to be
confoundedwithphysicalhealth,andthere
is evidence that depression is a more effec-
tive predictor of problems in diabetes self-
care (24). We did not code other aspects of
the intervention (e.g., pharmacological in-
terventions), partly because such data were
often not presented in detail.
Meta-regression has a number of
weaknesses (22). The analysis only repre-
sents an observational association and is
limited by the small sample size, which
also restricted the scope for the modeling
of interactions.
Implications for policy and practice
Although previous reviews have sug-
gested that psychological therapy can im-
prove both diabetes and mental health
outcomes (9,10), the current review has
been unable to identify the types of inter-
ventions that can impact on both.
Thereareanumberofreasonsforthis
failure. Providing such interventions re-
quires signiﬁcant expertise, and profes-
sionals may lack the necessary expertise
acrossmentalandphysicalhealth.There-
sults could also reﬂect difﬁculties for pa-
tients: modifying behavior to meet
guidelines for physical health in diabetes
requires signiﬁcant effort, and adding
mental health interventions may tax time,
attention, and motivation (25). Although
there may be useful therapeutic synergies
between conditions (e.g., exercise may
improve both A1C outcomes and depres-
sion),conditionsmayalsobeantagonistic
(2). For example, improvements in de-
pressive symptoms may cause an increase
in appetite and unhealthy eating, while
active monitoring of physical symptoms
may itself be distressing (11).
Managing mental and physical health
issues is an important part of care for long-
term conditions, and the current study
suggests that achieving integrated, biopsy-
chosocial care remains a signiﬁcant chal-
lenge. Interesting avenues for future
research might include the development of
interventionsdesignedaroundthemanage-
ment of comorbidity as a speciﬁc task (11)
or the identiﬁcation of particular groups of
patients that are amenable to an integrated
approach(e.g.,wheredepressioniscausally
related to the diabetes, as opposed to those
cases where they simply co-occur).
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